Andere Sprachen Cytophage Technologies Ltd.

Aktien

A4ZZ0X

CA2328211081

CYTO

Markt geschlossen - Toronto S.E. Andere Börsenplätze 21:59:05 21.06.2024			% 5 Tage	% 1. Jan.
0.39 ^CAD	0.00%		-11.36%	-44.65%

27.05.	Cytophage Technologies Ltd. stärkt den Vorstand	CI
30.04.	Cuspis Capital III Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Cytophage Expands Commercialization of Phage Products in Asian Poultry Market	20.06.
Cytophage CEO to Present at TEDx Winnipeg Event	04.06.
Cytophage Reports Q1 Financials and Provides Business Update	30.05.
Cytophage Technologies Ltd. Strengthens Board of Directors	27.05.
Cytophage Strengthens Board of Directors	27.05.
Cytophage Announces Fiscal Year End 2023 Results	30.04.
Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	30.04.
Cytophage Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	30.04.
Cytophage Technologies Ltd. Appoints Michael D. Cochrane as Newest Member of Board of Directors	16.04.
Cytophage Appoints New Board Director	16.04.
Cytophage Technologies Ltd. Provides Update on Bacteriophage Human Trial at The Ottawa Hospital	02.04.
Cytophage Provides Update on Bacteriophage Human Trial at The Ottawa Hospital	02.04.
Cytophage Provides Bacteriophages for Landmark Treatment of Joint Replacement Infection in Canada	01.03.
Cytophage Technologies Ltd. Provides Update on Upcoming Product for Egg Production in Canada	12.02.
Cytophage Update on Upcoming Product for Egg Production in Canada	12.02.
Cytophage Technologies Inc. completed the acquisition of Cuspis Capital III Ltd. (TSXV:CIII.P) in a reverse merger transaction.	02.02.
Cuspis Capital III Ltd. Announces Closing of Concurrent Financing by Cytophage Technologies Inc., Receipt of TSXV Conditional Approval, and Certain Loans	23.12.
Cuspis Capital III Ltd. announced that it has received CAD 2.5 million in funding	22.12.
Cuspis Capital III Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29.11.
Cuspis Capital III Ltd. and Cytophage Technologies Inc. Announce Execution of Business Combination Agreement and Concurrent Financing	06.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Cytophage Technologies Ltd.

Aktien

A4ZZ0X

CA2328211081

CYTO

Andere Sprachen

Filter